|7045152||Treating pulmonary disorders with gaseous agent causing repletion of GSNO|
Pulmonary disorders in which the GSNO pool or glutathione pool in the lung is depleted and where reactive oxygen species in lung are increased, are treated by delivering into the lung as a gas, agent causing repletion or increase of the GSNO pool or protection again...
|6866869||Liquid antimicrobial compositions|
A liquid antimicrobial composition comprises: (1) a mixture of iodide anions and thiocyanate anions; (2) periodic acid or an alkali metal salt thereof; and (3) optionally, a peroxidase.
|6001383||Cyanogen fumigants and methods of fumigation using cyanogen|
A fumigant, comprising cyanogen (C2 N2) provides a viable alternative to conventional fumigants such as methyl bromide, phosphine and carbonyl sulphide. Cyanogen (C2 N2) can be used as such a fumigant in the con...
|5972987||Method for removing nits from hair|
A method for removing lice eggs from the hair of an infested human or animal using a nit-visualizing composition. The composition involves the use of certain dyes which have an affinity to the surface of nits, to thereby enable a second individual to more...
|5503853||Prophylactic and therapeutic applications of peroxidases|
Prophylactic and therapeutic applications of peroxidases for the manufacture of medicaments for the treatment and prevention and treatment of enveloped virus infections and, in particular, of herpes simplex and immunodeficiency virus infections. The medic...
|5468715||Blended fungicide compositions|
This invention provides a novel fungicide composition which has bicarbonate-containing inorganic salt ingredients which enhance the efficacy of a fungicide ingredient for the treatment of cultivated crops. The fungicide composition contains nitrogen, phos...
|4885363||1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs|
Metal-chelating liquids having the formula ##STR1## wherein Y is oxygen or ##STR2## R1 is hydrogen, alkyl, arylalkyl aryl, alkoxy, hydroxyalkyl ##STR3## wherein G is ##STR4##...
|4800081||Methods and compositions for treating viral infections|
The disclosure demonstrates the inhibition of replication of human cytomegalovirus (HCMV) in cultured human embryo skin muscle cells by two separate subclasses of direct-acting smooth muscle relaxing agents alone or in combination with each other. These t...
|4528178||Chemotherapeutic agent and tracer composition and use thereof|
A therapeutic composition suitable for extracorporeal treatment of whole blood comprises a dialyzable chemotherapeutic agent and a dialyzable fluorescable tracer means. The removal rate of the fluorescable tracer compound from treated blood during hemodia...
|4338303||Treatment of parasitic diseases|
A method is disclosed herein for the treatment of parasitic diseases in animals such as birds and mammals, more specifically, in vivo and in vitro treatments of malaria, chagas disease and sleeping sickness with a compound comprising a unit of the formula...